EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study

Kai Yu iD, Shobana Athimulam iD, Jasmine Saini iD, Ravinder Jeet Kaur, Qingping Xue, Travis J McKenzie, Ravinder J Singh, Stefan Grebe, Irina Bancos iD

The Journal of Clinical Endocrinology & Metabolism · 17.03.2025 · 110 (4) · 1177-1186

DOI: 10.1210/clinem/dgae604 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.09.2024. Verfasst von Kai Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Adrenal Cortex Neoplasms, Biomarkers, Tumor, Steroids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Guidelines suggest performing urine steroid profiling in patients with indeterminate adrenal tumors to make a noninvasive diagnosis of adrenocortical carcinoma (ACC). However, urine steroid profiling is not widely available.

Objective

To determine the accuracy of clinically available serum 11-deoxycortisol, 17OH-progesterone, and 17OH-pregnenolone in diagnosing ACC.

Methods

We conducted a prospective single-center cohort study of patients with adrenal masses evaluated between 2015 and 2023. Serum was analyzed by liquid chromatography–mass spectrometry for 17OH-pregnenolone, 17OH-progesterone, and 11-deoxycortisol. Reference standard for adrenal mass included histopathology, imaging characteristics, imaging follow up of 2 years, or clinical follow up of 5 years. Localized Generalized Matrix Learning Vector Quantization analysis was used to develop serum steroid score and assessed with area under receiver operating curve.

Results

Of 263 patients with adrenal masses, 44 (16.7%) were diagnosed with ACC, 161 (61%) with adrenocortical adenomas (ACAs), 27 (10%) with other adrenal malignancies, and 31 (12%) with other. Hounsfield unit ≥ 20 was demonstrated in all ACCs, in all but 1 other adrenal malignancy, and in 58 (31%) ACAs. All 3 steroids were higher in patients with ACCs vs non-ACCs, including when comparing ACCs with functioning ACAs, and with ACAs with Hounsfield unit ≥ 20 (P < .0001 for all). Localized Generalized Matrix Learning Vector Quantization analysis yielded a serum steroid score that discriminated between ACC and non-ACC groups with a mean threshold fixed area under receiver operating curve of 0.823.

Conclusion

We showed that measurements of 11-deoxycortisol, 17OH-progesterone, and 17OH-pregnenolone could be valuable in diagnosing ACC. After appropriate validation, serum steroid score could be integrated in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenocortical CarcinomaAdrenal Cortex NeoplasmsBiomarkers, TumorSteroidsHumansMaleFemaleMiddle AgedProspective StudiesAdultAgedFollow-Up StudiesYoung AdultPrognosis

Stichwörter der Autor:innen

adrenal incidentalomaadrenocortical carcinomadiagnosissteroid

Substanzen

Biomarkers, TumorSteroids

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
  • Division of Endocrinology, Diabetes, Bone and Mineral Disorder, Henry Ford Health, Detroit, MI 48202, USA.
  • Department of Epidemiology and Biostatistics, School of Public Health, Chengdu Medical College, Chengdu, Sichuan 610041, China.
  • Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Laboratory medicine and Pathology, Mayo Clinic, Rochester, MN 555905, USA.

ORCID-Profile: Kai Yu, Shobana Athimulam, Jasmine Saini, Irina Bancos

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Yu, K., Athimulam, S., Saini, J., Kaur, R. J., Xue, Q., McKenzie, T. J., Singh, R. J., Grebe, S., & Bancos, I. (2025). Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism, 110(4), 1177-1186. https://doi.org/10.1210/clinem/dgae604

Vancouver

Yu K, Athimulam S, Saini J, Kaur RJ, Xue Q, McKenzie TJ, et al. Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2025;110(4):1177-1186. doi:10.1210/clinem/dgae604

BibTeX
@article{Yu2025,
  author = {Yu, Kai and Athimulam, Shobana and Saini, Jasmine and Kaur, Ravinder Jeet and Xue, Qingping and McKenzie, Travis J and Singh, Ravinder J and Grebe, Stefan and Bancos, Irina},
  title = {Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {4},
  pages = {1177--1186},
  doi = {10.1210/clinem/dgae604}
}
Kostenlos starten →